Next-generation sequencing provides an increasing wealth of information that can be helpful to improve patient care. However, optimal use of this information requires not only a detailed understanding of tumor biology, but also standard of care therapeutic recommendations, clinical trial options and a patients’ individual situation. Molecular tumor boards offer an opportunity to address this challenge by bridging the gap between molecular pathologists and medical oncologists. This session will explore different models for molecular tumor function and will highlight opportunities to improve patient care by bridging the pathology-oncology gap.
Precision Oncology Through a Molecular Tumor Board: Hype or Reality?
Marios Giannakis, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA
Cancer Clinical Decision Making Tools in the Era of Precision Medicine & Big Data
Mia Levy, MD, PhD, Rush University Medical Center, Chicago, IL, USA
Objectives:
- Understand the elements and operational considerations of a molecular tumor board.
- Describe the role of the molecular tumor board in guiding precision oncology.
- Understand how shared genomic resources and knowledgebases can contribute to precision oncology.
Recording Date: November 18, 2020
Continuing Education Credit Information
CME/CMLE credit: 1.50 hr
Last day to purchase course and CE claim credit: February 16, 2024
Note: Members of AMP can access this at a discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
